Literature DB >> 16585637

Characterization of bovine and human group B streptococci isolated in Turkey.

Ismail Hakki Ekin1, Kemal Gurturk1.   

Abstract

In the study, group B streptococci (GBS) isolated from bovines and humans in and around Van, eastern Turkey, were serotyped, and their haemagglutination and lectin-agglutination properties were also determined. This study is the first epidemiological survey of GBS serotypes performed in Turkey. A total of 148 GBS isolates, 76 from bovine milk and 72 from women attending a maternity polyclinic, were examined by co-agglutination, slide haemagglutination and slide lectin-agglutination tests. By the co-agglutination test, 34 (44.7%) of bovine isolates and 49 (68%) of human isolates could be serotyped. In bovine isolates, type VII (11.8%), III (10.5%), Ic (6.5%) and VIII (3.9%) were the most frequently detected serotypes. The most frequent human serotypes were Ic (33.3%), IV (8.3%), VIII (6.9%), V (5.5%) and R (5.5%). In the haemagglutination test using rabbit erythrocytes, 23 (33.3%) bovine and 15 (23.4%) human isolates were found to be positive. The bovine GBS isolates showed a significant positive agglutination reaction with Dolichos biflorus lectin (30.4 %), whereas the human GBS isolates were found to be positive for Arachis hypogea (18.8%) and Canavalia ensiformis (37.5%) lectins. The treatment of GBS with trypsin was also found to be important for the demonstration of the haemagglutination and lectin-agglutination properties of GBS. The results of the study provide data on serotype distribution and the formulation of a possible GBS vaccine in Turkey, and the lectin-agglutination tests may also be useful for differentiating bovine and human GBS strains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585637     DOI: 10.1099/jmm.0.46156-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States.

Authors:  Michelle J Diedrick; Aurea E Flores; Sharon L Hillier; Roberta Creti; Patricia Ferrieri
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

2.  Type IV neonatal early-onset group B streptococcal disease in a United States hospital.

Authors:  Karen M Puopolo; Lawrence C Madoff
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

3.  Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci.

Authors:  Fanrong Kong; Lotte Munch Lambertsen; Hans-Christian Slotved; Danny Ko; Hui Wang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

4.  Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada.

Authors:  Sarah Teatero; Allison McGeer; Aimin Li; Janice Gomes; Christine Seah; Walter Demczuk; Irene Martin; Jessica Wasserscheid; Ken Dewar; Roberto G Melano; Nahuel Fittipaldi
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

5.  Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages.

Authors:  Edmondo Campisi; C Daniela Rinaudo; Claudio Donati; Mara Barucco; Giulia Torricelli; Morven S Edwards; Carol J Baker; Imma Margarit; Roberto Rosini
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.